108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
一种基于磁敏感加权成像的可解释影像组学模型，用于无创预测肝细胞癌中的三级淋巴结构
Authors Liu L, Gao F, Li Y, Cheng J, Zhang H , Cai P, Chen W, Li X
Received 24 July 2025
Accepted for publication 23 September 2025
Published 30 September 2025 Volume 2025:12 Pages 2197—2211
DOI https://doi.org/10.2147/JHC.S551462
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr David Gerber
Lizhen Liu,1,* Fen Gao,1,* Yiman Li,1,* Jie Cheng,1,* Huarong Zhang,2 Ping Cai,1 Wei Chen,1 Xiaoming Li1
1 7T Magnetic Resonance Translational Medicine Research Center, Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, People’s Republic of China; 2Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wei Chen, Email landcw@tmmu.edu.cn Xiaoming Li, Email lxm359261069@tmmu.edu.cn
Background: Intratumoral tertiary lymphoid structures (iTLSs) are associated with favorable prognosis and immunotherapy response in hepatocellular carcinoma (HCC). This study aimed to develop an interpretable susceptibility-weighted imaging (SWI)-based radiomics model to non-invasively predict iTLSs in HCC.
Materials and Methods: A retrospective cohort of 477 HCC patients undergoing preoperative SWI was used (training: 290; validation: 125; independent validation: 62). Radiomics models were constructed using five machine learning algorithms: logistic regression, random forest (RF), support vector machine, extreme gradient boosting, and K-nearest neighbors. Model performance was evaluated using the area under the ROC curve (AUC), model interpretability was examined using shapley additive explanations (SHAP), and survival analyses were performed to assess clinical relevance.
Results: In the independent validation cohort, the RF algorithm was identified as the optimal classifier, with an AUC of 0.771 (95% CI: 0.641– 0.883), sensitivity of 78.6%, and specificity of 67.6%. It significantly outperformed the radiological model (p = 0.046), and showed comparable performance with the hybrid model in predicting iTLSs positivity (iTLSs+) (p > 0.05). SHAP analysis showed that radiomics features (logarithm_firstorder_Minimum and exponential_glszm_ZoneEntropy) were significant predictors of iTLSs+. Kaplan-Meier analysis demonstrated improved time-to-recurrence (TTR) in the iTLSs+ predictor group compared to the iTLSs-negativity (iTLSs-) predictor group (p < 0.05). Furthermore, patients in the iTLSs+ predictor group receiving tyrosine kinase inhibitors combined with immune checkpoint inhibitors (TKI-ICI) therapy exhibited significantly extended TTR (p < 0.05), while no benefit was observed in the iTLSs- predictor group.
Conclusion: The SWI-based radiomics model provided a non-invasive tool for predicting iTLSs+ in HCC and identifying patients who might benefit from TKI-ICI therapy, and it showed potential for future integration into clinical decision-making workflows.
Keywords: hepatocellular carcinoma, susceptibility-weighted imaging, magnetic resonance imaging, radiomics, tertiary lymphoid structures
1 7T Magnetic Resonance Translational Medicine Research Center, Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, People’s Republic of China; 2Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wei Chen, Email landcw@tmmu.edu.cn Xiaoming Li, Email lxm359261069@tmmu.edu.cn
Background: Intratumoral tertiary lymphoid structures (iTLSs) are associated with favorable prognosis and immunotherapy response in hepatocellular carcinoma (HCC). This study aimed to develop an interpretable susceptibility-weighted imaging (SWI)-based radiomics model to non-invasively predict iTLSs in HCC.
Materials and Methods: A retrospective cohort of 477 HCC patients undergoing preoperative SWI was used (training: 290; validation: 125; independent validation: 62). Radiomics models were constructed using five machine learning algorithms: logistic regression, random forest (RF), support vector machine, extreme gradient boosting, and K-nearest neighbors. Model performance was evaluated using the area under the ROC curve (AUC), model interpretability was examined using shapley additive explanations (SHAP), and survival analyses were performed to assess clinical relevance.
Results: In the independent validation cohort, the RF algorithm was identified as the optimal classifier, with an AUC of 0.771 (95% CI: 0.641– 0.883), sensitivity of 78.6%, and specificity of 67.6%. It significantly outperformed the radiological model (p = 0.046), and showed comparable performance with the hybrid model in predicting iTLSs positivity (iTLSs+) (p > 0.05). SHAP analysis showed that radiomics features (logarithm_firstorder_Minimum and exponential_glszm_ZoneEntropy) were significant predictors of iTLSs+. Kaplan-Meier analysis demonstrated improved time-to-recurrence (TTR) in the iTLSs+ predictor group compared to the iTLSs-negativity (iTLSs-) predictor group (p < 0.05). Furthermore, patients in the iTLSs+ predictor group receiving tyrosine kinase inhibitors combined with immune checkpoint inhibitors (TKI-ICI) therapy exhibited significantly extended TTR (p < 0.05), while no benefit was observed in the iTLSs- predictor group.
Conclusion: The SWI-based radiomics model provided a non-invasive tool for predicting iTLSs+ in HCC and identifying patients who might benefit from TKI-ICI therapy, and it showed potential for future integration into clinical decision-making workflows.
Keywords: hepatocellular carcinoma, susceptibility-weighted imaging, magnetic resonance imaging, radiomics, tertiary lymphoid structures